Year: 1994
Type: article
Abstract: Amyloid P (A@) is a 3943-residue protein that originates from proteolysis of the P-protein precursor (PPP) and accumulates in senile plaques in brains of Alzheimer's disease (AD) patients.Mutant PPP, which incorporates an AD-causing double mutation at positions 687- 688, has been shown to enhance AP production in transfected cells.In this work we investigate the susceptibility of the mutant PPP sequence to proteolytic cleavage by proteinases from human brain.Internally quenched fluorogenic substrates were used that encompass the NH,-terminal sequence of AP from wild-type PPP, the double mutant, and the two single substitutions.Proteinase activity in brain extract cleaved the mutant substrate 100-fold faster than the wild-type substrate and the partial mutants 25-fold faster.The major cleavage site in all substrates was at the amyloidogenic Asp' site.The brain activity appeared to be cathepsin D (CD), as indicated by similarities to purified CD in 1) the rate and site of substrates cleavage, 2) the pH optima, and 3) the sensitivity to pepstatin A. The increased activity against the mutant substrate was not shared by cathepsins B and C, pepsin, HIV proteinase, and Candida albicans Asp-proteinase.Furthermore, CD cleaved a substrate that incorporates the COOH terminus of AP at positions equivalent to Thr4' andAla42, at ratios of 68% and 32%, respectively.CD degraded AP 1-40 into six fragments but AP 1-42 was completely resistant to digestion, probably because of its aggregation characteristics.These results indicate that CD is capable of producing the cleavages resulting in AP production and that it may prove to be a 'suitable therapeutic target.The formation of extracellular amyloid deposits in brains of Alzheimer's disease (AD)' patients is one of the hallmarks of the disease.The major component of the amyloid is the 39-43residue peptide, known as amyloid-p (AP) (see Ref. 1 for review), which is derived by proteolytic processing of a 110-135-kDa integral membrane protein termed amyloid-p precursor protein (PPP) (1).Considerable evidence implicates AP in the etiology of AD, the strongest of which was obtained from a National Institute on Aging Grant AG10481.The costs of publication of
Source: Journal of Biological Chemistry
Institutions: Abbott (United Kingdom), Abbott (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W1483408272
